Medicare Enrolled
Dr. Joash Lazarus, M.D.
Neurology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lazarus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lazarus?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lazarus
Dr. Joash Lazarus is a neurology specialist in Atlanta, GA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Lazarus performed 18,450 Medicare services across 1,101 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lazarus received a total of $1,022,653 from 61 pharmaceutical and/or device companies across 1476 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lazarus is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 5% volume in GA
$1,022,653 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,450
Medicare services
Top 5% in GA for neurology
1,101
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,230 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
17,101 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
504 | $89 | $135 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
150 | $127 | $183 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
132 | $26 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $65 | $94 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $122 | $171 |
| New patient office visit, complex (60-74 min) | 71 | $159 | $222 |
| Balance and posture test A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment. |
60 | $35 | $57 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
55 | $157 | $279 |
| Chemical nerve block injection, 1-4 muscles An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated. |
38 | $100 | $186 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
32 | $110 | $262 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
29 | $48 | $60 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
24 | $98 | $139 |
| Chemical paralysis of salivary glands, bilateral Injection of a chemical agent to paralyze the salivary glands on both sides of the mouth. |
19 | $86 | $129 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
13 | $101 | $128 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
13 | $244 | $335 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,022,653
Total received (2018-2024)
Avg $146,093/year across 7 years
Top 0% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
1,476
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$949,377 (92.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$60,496 (5.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,781 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$195,069
2023
$163,810
2022
$177,956
2021
$158,338
2020
$88,984
2019
$140,265
2018
$98,232
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$50,436
TG Therapeutics, Inc.
$39,430
Teva Pharmaceuticals USA, Inc.
$36,941
MDD US Operations, LLC
$16,798
Neurocrine Biosciences, Inc.
$16,226
ACADIA Pharmaceuticals Inc
$11,085
E.R. Squibb & Sons, L.L.C.
$10,472
ABBVIE INC.
$7,554
Amneal Pharmaceuticals LLC
$4,292
Celgene Corporation
$385
Novartis Pharmaceuticals Corporation
$271
Lilly USA, LLC
$266
Biogen, Inc.
$184
Amgen Inc.
$120
Nevro Corp.
$109
UCB, Inc.
$93
Medtronic, Inc.
$84
Supernus Pharmaceuticals, Inc.
$63
ARGENX US, INC.
$54
Genentech USA, Inc.
$45
Mallinckrodt Hospital Products Inc.
$25
Eisai Inc.
$22
Axsome Therapeutics, Inc.
$22
Alexion Pharmaceuticals, Inc.
$22
Cycle Pharmaceuticals Inc
$21
CATALYST PHARMACEUTICALS, INC.
$20
PFIZER INC.
$18
LivaNova USA, Inc.
$14
Top 3 companies account for 65.0% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$164,091
EMD Serono, Inc.
$163,286
Biogen, Inc.
$122,643
ACADIA Pharmaceuticals Inc
$77,461
Allergan, Inc.
$61,968
Teva Pharmaceuticals USA, Inc.
$61,823
E.R. Squibb & Sons, L.L.C.
$60,086
Acorda Therapeutics, Inc
$59,024
MDD US Operations, LLC
$44,261
TG Therapeutics, Inc.
$43,620
ABBVIE INC.
$33,812
Neurocrine BioSciences, Inc.
$25,767
Celgene Corporation
$19,602
TG THERAPEUTICS, INC.
$19,266
US WorldMeds, LLC
$18,669
GENZYME CORPORATION
$13,011
Bayer HealthCare Pharmaceuticals Inc.
$4,945
Impax Laboratories, Inc.
$4,846
Genentech USA, Inc.
$4,819
Amneal Pharmaceuticals LLC
$4,368
Medtronic USA, Inc.
$2,882
Novartis Pharmaceuticals Corporation
$2,673
AbbVie Inc.
$2,049
Genentech, Inc.
$1,885
Janssen Pharmaceuticals, Inc
$1,438
Horizon Therapeutics plc
$480
UCB, Inc.
$347
Lilly USA, LLC
$335
Allergan Inc.
$333
Abbott Laboratories
$320
Amgen Inc.
$261
Supernus Pharmaceuticals, Inc.
$199
ITI, Inc.
$190
Avanir Pharmaceuticals, Inc.
$164
Boston Scientific Corporation
$150
Alexion Pharmaceuticals, Inc.
$143
Adamas Pharmaceuticals, Inc.
$132
Kyowa Kirin, Inc.
$130
SK Life Science, Inc.
$125
HARMONY BIOSCIENCES LLC
$115
Nevro Corp.
$109
PFIZER INC.
$95
SANOFI-AVENTIS U.S. LLC
$91
Janssen Scientific Affairs, LLC
$88
ARGENX US, INC.
$86
Medtronic, Inc.
$84
Neurelis, Inc.
$65
LivaNova USA, Inc.
$41
Otsuka Pharmaceutical Development & Commercialization, Inc.
$37
Catalyst Pharmaceuticals, Inc.
$28
Mallinckrodt Hospital Products Inc.
$25
Eisai Inc.
$22
Axsome Therapeutics, Inc.
$22
Lundbeck LLC
$21
Cycle Pharmaceuticals Inc
$21
CATALYST PHARMACEUTICALS, INC.
$20
BANNER LIFE SCIENCES, LLC
$19
Merz Pharmaceuticals, LLC
$18
Biohaven Pharmaceuticals, Inc.
$18
Greenwich Biosciences, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 44.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ACTHAR · ACTIVA · AIMOVIG · AJOVY · AMPYRA · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Activase · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaconnect · Briviact · CAPLYTA · COMIRNATY · COPAXONE · DUOPA · EMGALITY · Epidiolex · FYCOMPA · GILENYA · GOCOVRI · Gocovri · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · N'VISION · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · Ocrevus · Ongentys · Ozanimod · PERCEPT PC BRAINSENSE · Ponvory · QELBREE · QULIPTA · Qelbree · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SYNCHROMED · Senza · Sunosi · TECFIDERA · TROKENDI XR · TYSABRI · Tascenso ODT · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Wakix · XARELTO · XCOPRI · Xadago · Xeomin · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in GA.
Geographic Context
Neurologists within 10 mi
230
Per 100K population
21.5
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lazarus is a mixed practice specialist, with above-average Medicare volume (top 5% in GA), with speaking/promotional industry engagement in the top 0% of GA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lazarus experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Lazarus performed 17,101 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lazarus receive payments from pharmaceutical companies?
Yes. Dr. Lazarus received a total of $1,022,653 from 61 companies across 1,476 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lazarus's costs compare to other neurologists in Atlanta?
Dr. Lazarus's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lazarus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Atlanta
Browse neurologists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology